Press release
Immune Thrombocytopenia (ITP) Market is expected to grow modestly to $985m in 2025
Immune Thrombocytopenia (ITP) is an auto-immune-related bleeding disorder characterized by a low platelet count. Patients with severe ITP often experience fatigue, bruising, and reduced quality of life. Although most ITP cases are not fatal, approximately 3% of chronic refractory ITP patients die of complications, such as intracranial hemorrhage and infection. Most of the ITP treatments available are off-label drugs. In 2008, a class of new drug, the thrombopoietin receptor agonists (TRAs), was approved and revolutionized the treatment of ITP.
Request For Sample Report @ https://www.marketresearchreports.biz/sample/sample/1135703
GlobalData estimates the 2015 sales for ITP at approximately $928m across the 7MM covered in this report. The market is expected to grow modestly to $985m in 2025, at a CAGR of 0.6%. This growth will be mainly driven by the increasing uptake of TRAs, Amgen/Kirins Nplate/Romiplate (romiplostim) and Novartis Promacta/Revolade (eltrombopag). However, GlobalData expects, starting in 2022, Nplate and Promacta will face patent expiry and subsequent biosimilar/generic erosion; this represents the strongest barrier of ITP market growth.
Complete Report Details @ https://www.marketresearchreports.biz/reports/1135703/opportunityanalyzer-immune-thrombocytopenia-itp-opportunity-analysis-and-forecasts-to-2025-market-research-reports
The ITP pipeline activity is weak, with only one active late-stage pipeline agent, Rigel Pharmaceuticals fostamatinib; however, GlobalData expects this drug to struggle for uptake because of the modest efficacy shown in its pivotal trials. Overall, the treatment landscape of ITP is not anticipated to substantially change throughout the forecast period of 2015-2025.
Key Questions Answered
- What are the key drivers behind the increasing uptake and market penetration of the TRA-class molecules, since their approval in 2008, and what is the trend of TRA use in the forecast period?
- When will the key patent of Nplate and Promacta expire, and how will it affect drug sales and the overall ITP market in the 7MM?
- What are the struggles for pipeline drug development in the ITP market? Why does GlobalData expect the pipeline drugs to introduce minimal impacts on the marketspace during the forecast period?
Have Any Query? Ask Our Expert @https://www.marketresearchreports.biz/sample/enquiryBuy/1135703
Scope
- Overview of ITP, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and disease management.
- Annualized ITP therapeutics market revenue, cost of therapy per patient, and treatment usage patterns in three patient segments (including pediatric, adult primary, and adult secondary), forecast from 2015 to 2025.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the ITP therapeutics market
- Pipeline analysis: comprehensive data assessing emerging trends and mechanisms of action under development for ITP therapy. The most promising candidate in Phase III development is profiled.
- Analysis of the current and future market competition in the global ITP therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
Reasons to buy
The report will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global ITP therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global ITP therapeutics market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact Us
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Email: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immune Thrombocytopenia (ITP) Market is expected to grow modestly to $985m in 2025 here
News-ID: 657755 • Views: …
More Releases from MarketResearchReports.biz
Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in…
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume…
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with…
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is…
More Releases for ITP
Immune Thrombocytopenia ITP Market Booming with New Therapeutic Approaches | Coh …
📊 Immune Thrombocytopenia ITP Market Snapshot 2025-2032
Immune Thrombocytopenia (ITP) Market is expected to reach USD 3.1 Billion by 2032, growing at a CAGR of 4.9% during 2025 to 2032.
Coherent Market Insights unveils its latest data-driven Immune Thrombocytopenia ITP Market Research Report featuring transformative insights into the U.S. Immune Thrombocytopenia ITP Market. Spanning from 2025 to 2032, this report offers granular forecasts, payer-provider models, and supply chain intelligence. As the U.S.…
ITP Therapeutics Market to Reach US$ 1.0 Billion by 2032: Fact.MR
The global Idiopathic Thrombocytopenic Purpura (ITP) therapeutics market has experienced notable growth in recent years, driven by factors such as increased awareness of autoimmune diseases, advancements in targeted therapies, and a rising prevalence of ITP among the geriatric population. According to Fact.MR, the market was valued at approximately US$ 587.0 million in 2021 and is projected to reach US$ 1.0 billion by 2032, reflecting a compound annual growth rate (CAGR)…
Exploring the Idiopathic Thrombocytopenic Purpura (ITP) Treatment Drugs Market
Idiopathic Thrombocytopenic Purpura (ITP), also known as Immune Thrombocytopenic Purpura, is an autoimmune disorder characterized by abnormally low platelet levels, leading to an increased risk of bruising and bleeding. The condition can affect both children and adults, with treatment options tailored to individual cases based on severity and response to therapy. The growing prevalence of ITP and advancements in treatment approaches have fueled the demand for effective therapeutic drugs, making…
Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Analysis and Futur …
The world of the idiopathic thrombocytopenic purpura (itp) therapeutics market is a complex and ever-evolving landscape, shaped by consumer demands and technological advancements. In this report, we delve into the depths of this market to provide a profound and comprehensive analysis, catering to a diverse audience that includes manufacturers, suppliers, distributors, and investors. Our primary goal is to empower industry stakeholders with invaluable insights to make informed decisions in a…
Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market - Competitive Land …
Idiopathic Thrombocytopenic Purpura (ITP) is a condition into which blood doesn't clot normally or failure to blood clot. This condition is commonly referred to as immune thrombocytopenia. ITP can lead to irregular bleeding and brushing. Frequent low blood counts especially platelets and thrombocytes often lead to ITP. Various drug class are available to treat this condition but corticosteroids are the first line therapy.
Download Sample Brochure at: https://www.theinsightpartners.com/sample/TIPRE00016880/?utm_source=OpenPR&utm_medium=10766
Market Dynamics:
The…
Idiopathic Thrombocytopenic Purpura Market - Defy the Odds: Transforming Lives t …
Newark, New Castle, USA: The "Idiopathic Thrombocytopenic Purpura Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Idiopathic Thrombocytopenic Purpura Market: https://www.growthplusreports.com/report/idiopathic-thrombocytopenic-purpura-market/8875
This latest report researches the industry structure,…
